Understanding the problems developing a healthy living programme in patients with serious mental illness: A qualitative study

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Pearsall, Robert ^a   Hughes, Susan ^b   Geddes, John ^c   Pelosi, Anthony ^d  

^a MONKLANDS HOSPITAL   (United Kingdom)

^b Community Health Clinic ^*  (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ST JOHN'S HOSPITAL   (United Kingdom)

Author keywords

Healthy living; Healthy living programme; Physical health; Qualitative study; Serious mental illness

Indexed keywords

FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HEALTH STATUS; HUMAN; LIFESTYLE; MALE; MENTAL DISEASE; MENTAL PATIENT; MIDDLE AGED; OBESITY; PSYCHOLOGY; QUALITATIVE RESEARCH; SMOKING;

FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; MENTAL DISORDERS; MENTALLY ILL PERSONS; MIDDLE AGED; OBESITY; QUALITATIVE RESEARCH; SMOKING;

EID: 84893714132     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-38     Document Type: Article

References (33)

1. The Schizophrenia Commission The abandoned illness: a report from the schizophrenia commission. 2012, London: Rethink Mental Illness, The Schizophrenia Commission.
2. Roberts L, Roalfe A, Wilson S, Lester H. Physical health care of patients with schizophrenia in primary care: a comparative study. Fam Pract 2007, 24:34-40.
3. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch Gen Psychiatry 2007, 64(10):1123-1131. 10.1001/archpsyc.64.10.1123, 17909124.
4. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997, 171(12):502-508.
5. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007, 116:317-333. 10.1111/j.1600-0447.2007.01095.x, 17919153.
6. Goff DC, Sullivan LM, McEvoy JP. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 2005, 80:45-53. 10.1016/j.schres.2005.08.010, 16198088.
7. De Hert M, Schreurs V, Vancampfort D, Van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009, 8:15-22. 2656262, 19293950.
8. Newcomer JW, Haupt DW. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002, 59:337-345. 10.1001/archpsyc.59.4.337, 11926934.
9. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio PL. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996, 37:68-73. 10.1016/S0010-440X(96)90054-1, 8770530.
10. Filik R, Sipos A, Kehoe PG, Burns T, Cooper SJ. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand 2006, 113:298-305. 10.1111/j.1600-0447.2006.00768.x, 16638074.
11. Ryan M, Collins P, Thakore J. Impaired fasting glucose tolerance in first episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003, 160:284-289. 10.1176/appi.ajp.160.2.284, 12562574.
12. Tosh G, Clifton A, Mala S, Bachner M. Physical health care monitoring for people with serious mental illness. Cochrane Database Syst Rev 2010, CD008298(1).
13. The Scottish, Government Scottish health survey. 2010, Edinburgh: The Scottish Government, http://www.scotland.gov.uk/publications, The Scottish, Government.
14. Brown S, Birtwistle J. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999, 29(3):697-701. 10.1017/S0033291798008186, 10405091.
15. Green A, Patel J, Goisman R. Weight gain from novel antipsychotics drugs: need for action. Gen Hosp Psychiatry 2000, 22:224-235. 10.1016/S0163-8343(00)00081-5, 10936629.
16. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999, 156(11):1686-1696.
17. Daumit GL, Goldberg RW, Anthony C, Dickerson F. Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis 2005, 193:641-646. 10.1097/01.nmd.0000180737.85895.60, 16208158.
18. Paton C, Esop R, Young C. Obesity, dyslipidaemias, and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatr Scand 2004, 110:299-305. 10.1111/j.1600-0447.2004.00372.x, 15352932.
19. Muir-Cochrane E. Medical co-morbidity risk factors and barriers to care for people with schizophrenia. J Psychiatr Mental Health Nurs 2006, 13(4):447-452.
20. George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry 2008, 63:1092-1096. 10.1016/j.biopsych.2007.11.002, 2693008, 18096137.
21. Mauri M, Simoncini M, Castrogiovanni S, Iovieno N, Cecconi D. A psychoeducational programme for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry 2008, 41:17-23. 10.1055/s-2007-992148, 18203047.
22. Lawn SJ, Pols RG, Barber JG. Smoking and quitting: a qualitative study with community-living psychiatric clients. Soc Sci Med 2002, 54:93-104. 10.1016/S0277-9536(01)00008-9, 11820684.
23. Pearsall R. Improving healthy living in adults with serious mental illness 2012, DPhil thesis: University of Oxford.
24. Cresswell JW. Qualitative inquiry and research design 1998, Thousand Oaks, London: Sage Publications.
25. NVivo Qualitative software, version 8.0 http://www.qsrinternational.com, NVivo.
26. Scottish Office Towards a healthier Scotland - A white paper on health 1999, Edinburgh, http://www.scotland.gov.uk, Scottish Office.
27. Scottish health survey 2008, Edinburgh: The Scottish Government, http://www.scotland.gov.uk/publications.
28. Kerr S, Woods C, Knussen C, Watson H, Hunter R. Breaking the habit: a qualitative exploration of barriers and facilitators to smoking cessation in people with enduring mental health problems. BMC Public Health 2013, 13(1):221. 10.1186/1471-2458-13-221, 3599988, 23497231.
29. McDevitt J, Snyder M, Miller A, Wilbur J. Perceptions of barriers and benefits to physical activity among outpatients in psychiatric rehabilitation. J Nurs Scholarsh 2006, 38(1):50-55. 10.1111/j.1547-5069.2006.00077.x, 16579324.
30. Johnstone R, Nicol K, Donaghy M, Lawrie S. Barriers to update of physical activity in community-based patients with schizophrenia. J Ment Health 2009, 18(6):523-532.
31. Miller JB. Hospital admission for schizophrenia and bipolardisorder. Brit Med J 2011, 343:d5652. 10.1136/bmj.d5652, 21914767.
32. Brunero S. Systematic screening for metabolic syndrome in consumers with severe mental illness. Int J Ment Health Nurs 2009, 18(2):144-150. 10.1111/j.1447-0349.2009.00595.x, 19290978.
33. De Hert M, Vancampfort D, Correll CU, Mercken V, Peuskens J, Sweers K, van Winkel R, Mitchell AJ. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry 2011, 199(2):99-105. 10.1192/bjp.bp.110.084665, 21804146.